Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (BAX)
NYSE:BAX
Baxter International (BAX) Stock Price & Analysis
1,223 Followers
BAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$30.55 - $49.12
Previous Close$39.57
Volume1.31M
Average Volume (3M)3.59M
Market Cap
$20.37B
Enterprise Value$31.45B
Total Cash (Recent Filing)$3.19B
Total Debt (Recent Filing)$14.24B
Price to Earnings (P/E)-88.7
Beta0.82
Next Earnings
May 02, 2024EPS Estimate
$0.61Last Dividend Ex-Date
Feb 29, 2024Dividend Yield2.9%
Share Statistics
EPS (TTM)-0.45
Shares Outstanding507,827,437
10 Day Avg. Volume3,052,328
30 Day Avg. Volume3,587,361
Standard Deviation0.08
R-Squared0.19
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-4.89
Price to Sales (P/S)5.42
Price to Cash Flow (P/CF)9.60
P/FCF Ratio12.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.12
Enterprise Value/Gross Profit6.32
Enterprise Value/Ebitda35.98
Forecast
1Y Price Target
$45.00Price Target Upside13.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Baxter International News
PremiumCompany Announcements
Baxter International Weighs Sale Over Spinoff for Kidney Care
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst expects BAX's US Infusion System sales to grow significantly following the Novum IQ launch.
Product ApprovalFDA cleared BAX’s Novum IQ large volume pump, indicating potential unanticipated revenue.
Strategic DivestituresPotential sale of KidneyCo could yield significant cash for BAX, enhancing shareholder value.
Bears Say
Competitive LandscapeAlaris was approved ahead of Novum IQ, potentially reducing the anticipated upside for BAX.
Financial Guidance2024 sales growth guidance for BAX slightly lagged behind the consensus target.
Strategic DecisionsExiting KidneyCo may result in a setback in earnings per share growth for BAX.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BAX FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was $30.55 and its highest was $49.12 in the past 12 months.
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is May 02, 2024 which is in 13 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on Feb 08, 2024. The company reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.864 by $0.016.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 2.9%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is $0.61.
How many shares outstanding does Baxter International have?
Baxter International has 508,000,000 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of $0.88 in its last earnings report, beating expectations of $0.864. Following the earnings report the stock price went up 2.762%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Dodge & Cox. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$45.00 (13.55% Upside)
$45.00 (13.55% Upside)
Blogger Sentiment
Bullish
BAX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 39.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.37%
12-Months-Change
Fundamentals
Return on Equity
-0.44%
Trailing 12-Months
Asset Growth
-0.04%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
BAX Company Deck
---
BAX Earnings Call
Q4 2024
0:00 / 0:00
---
BAX Net sales Breakdown
33.83% Medical Products and Therapies
30.06% Kidney Care
20.34% Healthcare Systems and Technologies
15.18% Pharmaceuticals
0.59% Other
---
BAX Stock 12 Months Forecast
Average Price Target
$45.00
▲(13.55% Upside)
Technical Analysis
Best Analysts Covering BAX
1 Year
1 Year Success Rate
8/20 ratings generated profit
1 Year Average Return
-2.72%
assigned a buy rating 18 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -2.72% per trade.
---